Eam Investors, LLC Ventyx Biosciences, Inc. Transaction History

Eam Investors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jul 12, 2023	BUY	$29.51 - $46.65 $1.91 Million - $3.02 Million	64,733 New	64,733 $2.17 Million
Q4 2022 Feb 14, 2023	SELL	$24.16 - $36.38 $442,393 - $666,154	-18,311 Reduced 22.0%	64,927 $2.13 Million
Q3 2022 Nov 14, 2022	BUY	$12.64 - $38.7 $1.05 Million - $3.22 Million	83,238 New	83,238 $2.91 Million

125

52.9M

35.3K

83K

Ticker VTYX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,527,200
Market Cap $135M
Description
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.